| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/30/2004 | CN1155405C Recipe and prepn. of medicine for treating diabetic ulcer and preparation method |
| 06/30/2004 | CN1155404C Method of preveting TPO adsorption and stable TPO-contg. composition |
| 06/30/2004 | CN1155403C Therapeutic uses of BPI protein products in humans with hemorrhage due to trauma |
| 06/30/2004 | CN1155402C Compounds that inhibit interaction between signal-transducing proteins and GLGF(PDZ/DHR) domain and uses thereof |
| 06/30/2004 | CN1155373C S-(3-hydroxypropyl)-L-cysteine composition as oral medicine |
| 06/29/2004 | US6756523 Adenovirus vectors for the transfer of foreign genes into cells of the central nervous system particularly in brain |
| 06/29/2004 | US6756511 Treating alzheimer's disease by preventing formation of insoluble amyloid beta and arresting its production |
| 06/29/2004 | US6756493 A polypeptide of neisseria spp, e.g, of neisseria gonorrhoeae |
| 06/29/2004 | US6756491 Receptor polypeptide for use in the treatment of urogenital disorders and cushing's syndrome |
| 06/29/2004 | US6756482 Purified human activin and process for producing the same |
| 06/29/2004 | US6756481 IL-23 receptor binding compositions |
| 06/29/2004 | US6756480 Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein |
| 06/29/2004 | US6756479 Isolated polypeptide of given sequence; use in differentiation of monocytes and as a anti-proliferative agent for lung tumor cells |
| 06/29/2004 | US6756477 Comprise breast tumor proteins, immunogenic portions thereof, or polynucleotides that encode such portions |
| 06/29/2004 | US6756407 Administering a compound which acts on a mid-brain pathway to increase blood flow in the ilio-hypogastric-pudendal arterial bed and genitalia |
| 06/29/2004 | US6756401 Drug mixtures comprising estrogen agonists or antagonists and anticholesterol statins, administered to promote bone formation, prevent bone disorders and/or as anticholesterol agents |
| 06/29/2004 | US6756362 Anionic polymers including dermatan sulfate, chondroitin sulfate, keratan sulfate, heparan sulfate, heparin, dextran sulfate, pentosan polysulfate, hyaluronic acid and alginate. |
| 06/29/2004 | US6756361 Overcoming antibiotic resistance |
| 06/29/2004 | US6756358 Promoter for chondrocyte proliferation agent; administering hepatocyte growth factor |
| 06/29/2004 | US6756357 Variants of human ciliary neurotrophic factor (hCNTF) |
| 06/29/2004 | US6756356 For inhibiting functions such as cell adhesion and the formation of tissue permeability barriers |
| 06/29/2004 | US6756355 HMGI proteins in cancer and obesity |
| 06/29/2004 | US6756354 Stabilization of drugs |
| 06/29/2004 | US6756228 Atherosclerosis susceptibility gene locus 1 (Athsq1) and atherosclerosis susceptibility gene locus 2 (Athsq2) |
| 06/29/2004 | US6756227 Used as prophylactic and/or therapeutic agents and polypeptides in medicine |
| 06/29/2004 | US6756213 Nucleic acid encoding retinoic acid receptor |
| 06/29/2004 | US6756211 Neutropohil inhibitors |
| 06/29/2004 | US6756206 Adsorption and removal of endotoxin from physiological fluids using cationic helix peptides |
| 06/29/2004 | US6756205 Vasoactive peptide for use in the treatment of inflammtion, congestive heart failure, migraines, diabetes and sepsis |
| 06/29/2004 | US6756041 Process for preparing conjugate vaccines including free protein and the conjugate vaccines, immunogens, and immunogenic reagents produced by this process |
| 06/29/2004 | US6756038 Agonist and antagonist peptides of carcinoembryonic antigen (CEA) |
| 06/29/2004 | US6756036 Methods for treating cancer using PSCA antibodies and fragments thereof |
| 06/29/2004 | CA2410699C Methods and compositions for inhibiting angiogenesis |
| 06/29/2004 | CA2315230C Anti-cryptococcal peptides |
| 06/29/2004 | CA2294476C Semaphorin receptors |
| 06/29/2004 | CA2242347C A method and use of polypeptide in sperm-egg binding to enhance or decrease fertility |
| 06/29/2004 | CA2133089C Novel cyclic amino acids and derivatives thereof |
| 06/29/2004 | CA2084163C Endothelin antagonistic substance |
| 06/29/2004 | CA2038669C Production of biologically active, recombinant members of the ngf/bdnf family of neurotrophic proteins |
| 06/29/2004 | CA2031518C Endothelial cell-leukocyte adhesion molecules (elams) and molecules involved in leukocyte adhesion (milas) |
| 06/27/2004 | CA2451588A1 Protein having active sulfate transporter activity and method for detecting canceration of tissue |
| 06/24/2004 | WO2004053495A1 Diagnostics and therapeutics for diseases associated with phosphodiesterase 9a1 (pde9a1) |
| 06/24/2004 | WO2004053494A1 DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN PHOSPHODIESTERASE 9a2 (PDE9a2) |
| 06/24/2004 | WO2004053493A1 Diagnostics and therapeutics for diseases associated with human phosphodiesterase 9a4 (pde9a4) |
| 06/24/2004 | WO2004053492A1 Diagnostics and therapeutics for diseases associated with human phosphodiesterase 9a3 (pde9a3) |
| 06/24/2004 | WO2004053453A2 Modulation of bub 1-beta expression |
| 06/24/2004 | WO2004053168A1 Modulation of adipophilin expression |
| 06/24/2004 | WO2004053167A1 Modulation of cd1d expression |
| 06/24/2004 | WO2004053162A1 Method of distinguishing drug-resistance of hepatitis b virus |
| 06/24/2004 | WO2004053142A2 P53-associated parkin-like cytoplasmic protein, and related compositions and methods |
| 06/24/2004 | WO2004053128A1 Mutations in gaba-b receptor 1 associated with epilepsy |
| 06/24/2004 | WO2004053103A2 METHOD OF INTRODUCING siRNA INTO ADIPOCYTES |
| 06/24/2004 | WO2004053099A2 A method for treatment of drug addiction and for screening of pharmaceutical agents therefor |
| 06/24/2004 | WO2004053098A2 Base, a new cancer gene, and uses thereof |
| 06/24/2004 | WO2004053093A2 Method of inhibiting neural transmission mediated by serotonin-2a and enhancing sensorimotor gating |
| 06/24/2004 | WO2004053083A2 Modulation of fetoprotein transcription factor expression |
| 06/24/2004 | WO2004053078A2 METHODS FOR MODULATING IKKα ACTIVITY |
| 06/24/2004 | WO2004053073A2 HIGH EFFICACY ANTISENSE Riα PKA POLY-DNP OLIGORIBONUCLEOTIDES |
| 06/24/2004 | WO2004053063A2 Molecular determinants of myeloma bone disease and uses thereof |
| 06/24/2004 | WO2004053061A2 Methods of therapy and diagnosis using targeting of cells that express lax |
| 06/24/2004 | WO2004053060A2 ANTISENSE MODULATION OF mitoNEET EXPRESSION |
| 06/24/2004 | WO2004053058A2 Junctional adhesion molecule splice variants |
| 06/24/2004 | WO2004053057A2 Gene expression systems and recombinant cell lines |
| 06/24/2004 | WO2004052931A1 Negatively charged antiviral protein conjugates |
| 06/24/2004 | WO2004052929A2 Recombinant cell line |
| 06/24/2004 | WO2004052927A1 A baldness related gene and the polypeptide encoded thereby, and uses thereof |
| 06/24/2004 | WO2004052924A1 Expression of peptides of the cytoplasmic domain of hiv-gp41 for inhibiting viral infections |
| 06/24/2004 | WO2004052922A2 Peptides, antibodies thereto, and their use in the treatment of central nervous system damage |
| 06/24/2004 | WO2004052921A1 Cyanomethyl derivatives as cysteine protease inhibitors |
| 06/24/2004 | WO2004052920A2 Conversion of apoptotic proteins |
| 06/24/2004 | WO2004052919A2 Peptide deformylase inhibitors |
| 06/24/2004 | WO2004052917A2 Hla-a1, a2 -a3,-a24,-b7,and -b44 tumor associated antigen peptides and compositions |
| 06/24/2004 | WO2004052916A2 Novel cyclic peptides comprising cis-3 aminocycloalkanecarboxylic acids |
| 06/24/2004 | WO2004052915A2 Novel cyclic peptides comprising alpha-, beta- and gamma- amino acids |
| 06/24/2004 | WO2004052914A2 Compositions and methods for inhibiting malaria protease falcipain-2 |
| 06/24/2004 | WO2004052910A1 A full-length polynucleotide coding chicken type ii collagen and the use of it |
| 06/24/2004 | WO2004052844A1 Prodrugs of gaba analogs, compositions and uses thereof |
| 06/24/2004 | WO2004052773A2 Peptide nanostructures, methods for their preparation and use |
| 06/24/2004 | WO2004052413A1 Wound dressings containing an enzyme therapeutic agent |
| 06/24/2004 | WO2004052404A2 Glycogen synthase kinase-3 inhibitors |
| 06/24/2004 | WO2004052391A1 Novel use of edg receptors |
| 06/24/2004 | WO2004052390A1 Methods and compositions for treating polycystic ovary syndrome |
| 06/24/2004 | WO2004052389A2 Nogo, caspr, f3 nb-3 useful in the treatment of injury and disease to the central nervous system |
| 06/24/2004 | WO2004052368A1 Use of certain compounds in treatment of obesity |
| 06/24/2004 | WO2004052360A1 Prodrugs of fused gaba analogs, pharmaceutical compositions and uses thereof |
| 06/24/2004 | WO2004052344A1 Improved carrier system for cyclosporin pharmaceutical compositions |
| 06/24/2004 | WO2004052341A1 Adjuvant compositions containing a sugar in crystalline form and aminoalkyl glucosaminide-4-phosphate |
| 06/24/2004 | WO2004052311A2 Modulation of acteyl-coa acetyltransferase 2 expression |
| 06/24/2004 | WO2004052308A2 Topical anti-infective formulations |
| 06/24/2004 | WO2004052305A2 Lactoferrin as an agent in the prevention of organ transplant rejection and graft-versus-host-disease |
| 06/24/2004 | WO2004052304A2 Antibacterial compounds having a (pyrrole carboxamide)-(benzamide)-(imidazole carboxamide) motif |
| 06/24/2004 | WO2004052295A2 Compositions and methods for nutrition supplementation |
| 06/24/2004 | WO2004052292A2 Histone deacetylase inhibitor enhancement of trail-induced apoptosis |
| 06/24/2004 | WO2004052290A2 Compositions, splice variants and methods relating to breast specific genes and proteins |
| 06/24/2004 | WO2004052284A2 Treatment of diabetes |
| 06/24/2004 | WO2004052281A2 Oral lactoferrin in the treatment of sepsis |
| 06/24/2004 | WO2004052276A2 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 06/24/2004 | WO2004052273A2 Pharmaceutical compositions preparation of peptides, secreted by the snake venom glands |
| 06/24/2004 | WO2004052236A2 Methods and compositions for treatment of otitis media |
| 06/24/2004 | WO2004052233A2 Canine rankl and methods for preparing and using the same |